Today: 9 June 2026
Browse Category

NASDAQ:BMNR 21 January 2026 - 9 June 2026

BitMine Stock Gains as Ether Holdings Approach 5% Target

BitMine Stock Gains as Ether Holdings Approach 5% Target

BitMine Immersion Technologies shares jumped 6% after revealing ether holdings climbed to 5.54 million tokens, now 4.59% of Ethereum’s supply, with $9.6 billion in crypto, cash and stakes. The company priced a $273.8 million preferred stock offering, with proceeds possibly funding more ETH purchases and staking. BitMine projects $230 million in annualized staking revenues but warns of risks if ETH or financing falters.
Bitmine Stock Heads Into Key Week With $12.3 Billion Ether Play and Russell Review

Bitmine Stock Heads Into Key Week With $12.3 Billion Ether Play and Russell Review

Bitmine Immersion Technologies shares closed at $19.27 Friday, up 0.1% for the day and 2.1% since May 22, after landing on FTSE Russell’s preliminary Russell 3000 additions list. The crypto-treasury firm reported $12.3 billion in crypto, cash, and investments, mostly in Ether, but posted a $3.82 billion quarterly net loss, citing $3.78 billion in unrealized digital asset losses and flagging Ether price and staking risks.
Bitmine Shares in Focus as $12.3B Ether Pile Faces Russell Index Review

Bitmine Shares in Focus as $12.3B Ether Pile Faces Russell Index Review

Bitmine Immersion Technologies shares rose 1% to $19.43 Friday as traders reacted to its large Ether holdings and inclusion on FTSE Russell’s draft list for U.S. index additions. The company reported $12.3 billion in crypto, cash, and investments, including 5.39 million ETH and 203 bitcoin. Chairman Thomas Lee said Bitmine is staking more ETH than any other entity, with annualized rewards at $276 million. Final Russell 3000 reconstitution is set for June 26.
BitMine Immersion Technologies (BMNR) Hits an Ethereum Turning Point as Tom Lee Signals Slower Buying

BitMine Immersion Technologies (BMNR) Hits an Ethereum Turning Point as Tom Lee Signals Slower Buying

BitMine Immersion Technologies may slow its weekly ether purchases as it nears a target to own 5% of ETH supply, Chairman Tom Lee said Friday. The company held 5.18 million ETH as of May 4, equal to 4.29% of supply, and shares last traded at $22.17. Lee told a Miami conference the firm had been buying over 100,000 ETH a week but could shift focus as it approaches its goal.
Bitmine Immersion Technologies (BMNR) Stock Falls Even as ETH Holdings Reach 4.73 Million Tokens

Bitmine Immersion Technologies (BMNR) Stock Falls Even as ETH Holdings Reach 4.73 Million Tokens

Bitmine Immersion Technologies shares dropped 1% to $19.45 Thursday despite reporting $10.7 billion in crypto, cash, and related holdings, with 4.73 million ether as of March 29. Ether fell 4% to $2,066. Bitmine said 3.1 million ether was staked, valued at $6.3 billion, and annualized staking revenue reached $177 million. The company recently launched its own staking platform and acquired Australia’s Pier Two.
BMNR stock slides after Bitmine Immersion Technologies launches MAVAN despite B. Riley target hike

BMNR stock slides after Bitmine Immersion Technologies launches MAVAN despite B. Riley target hike

Bitmine Immersion Technologies shares fell 8% to $19.47 Thursday, despite launching its MAVAN Ethereum staking platform and a price target hike from B. Riley to $33. The company reported 3.14 million staked ETH worth $6.8 billion and projected annual staking rewards near $300 million. Crypto markets broadly declined, with ether down over 4%.
Bitmine (BMNR) boosts Ethereum holdings to 4.66 million tokens, but treasury value slips to $11 billion

Bitmine (BMNR) boosts Ethereum holdings to 4.66 million tokens, but treasury value slips to $11 billion

Bitmine Immersion Technologies’ ether holdings rose to 4.66 million tokens as of March 22, but the total value of its crypto, cash, and equity portfolio fell to $11.0 billion from $11.5 billion a week earlier as ether prices slipped. Bitmine staked 3.14 million ETH, or 67% of its holdings, and reported annualized staking revenues of $184 million. BMNR shares were last down about 1% at $20.94 early Monday.
Bitmine Immersion Technologies stock price: BMNR ticks up in premarket after 10% surge as ether firms

Bitmine Immersion Technologies stock price: BMNR ticks up in premarket after 10% surge as ether firms

Bitmine Immersion Technologies (BMNR) rose 0.1% to $21.53 in premarket trading Thursday after a 10.6% jump Wednesday. Ether climbed 6.7% to $2,067, boosting crypto-linked stocks. BMNR traded 60.1 million shares Wednesday, swinging between $20.49 and $22.17. Investors await Friday’s U.S. inflation data for signals on risk assets.
Bitmine stock slips in premarket after $10 billion crypto-and-cash update puts ETH bet back in focus

Bitmine stock slips in premarket after $10 billion crypto-and-cash update puts ETH bet back in focus

Bitmine Immersion Technologies shares fell about 3% in premarket trading Monday after the company reported $10 billion in crypto and cash holdings, including 4.3 million ether tokens. The stock last closed at $20.47. Bitmine plans to launch its MAVAN staking network in Q1 2026. Traders are watching ether and bitcoin prices after a volatile week for crypto-linked stocks.
BitMine Immersion (BMNR) stock whipsaws with ether — what to watch before Monday

BitMine Immersion (BMNR) stock whipsaws with ether — what to watch before Monday

BitMine Immersion Technologies shares rose 16.8% to $20.32 Friday after a 14.3% drop Thursday, tracking sharp swings in ether and bitcoin. Trading volume hit 54 million shares. The company held over 4.2 million ether and 193 bitcoin as of Feb. 1, with nearly 2.9 million ether staked, according to an SEC filing. Crypto price moves over the weekend are expected to drive Monday’s open.
7 February 2026
BitMine Immersion (BMNR) stock bounces premarket after Thursday rout as ether trades below $2,000

BitMine Immersion (BMNR) stock bounces premarket after Thursday rout as ether trades below $2,000

BitMine Immersion shares rose 8.7% to $18.91 in premarket trading Friday after plunging 14.3% the previous session. Ether dropped nearly 5%, settling near $1,955, while Bitcoin hovered around $67,421. Crypto-linked stocks including Coinbase and Marathon Digital also fell sharply before the open. BitMine holds over 4.2 million ether tokens and plans to launch its MAVAN staking network by Q1 2026.
6 February 2026
BMNR stock slips as BitMine’s $10.7 billion crypto stash keeps its ether bet in focus

BMNR stock slips as BitMine’s $10.7 billion crypto stash keeps its ether bet in focus

BitMine Immersion Technologies shares fell 3.1% to $22.09 Tuesday, tracking a 1% drop in ether to $2,293. The company disclosed holdings of 4.29 million ETH and $10.7 billion in crypto, cash, and investments as of Feb. 1. BitMine bought 41,788 ETH last week and stakes about 2.9 million ETH. Its MAVAN validator network remains on track for a Q1 2026 launch.
BitMine Immersion Technologies stock price: BMNR heads into Monday after Friday slide, ether drop

BitMine Immersion Technologies stock price: BMNR heads into Monday after Friday slide, ether drop

BitMine Immersion Technologies (BMNR) fell nearly 6% to $25.10 Friday as ether and bitcoin prices dropped sharply over the weekend. The company disclosed president Erik Nelson’s exit in a Jan. 28 SEC filing, with $585,000 in severance. BMNR reported holding 4.24 million ether and plans to ramp up staking. Crypto-linked stocks showed mixed results ahead of Monday’s market open.
1 February 2026
BitMine Immersion (BMNR) stock tumbles 10% as president exit filing hits and crypto slides

BitMine Immersion (BMNR) stock tumbles 10% as president exit filing hits and crypto slides

BitMine Immersion Technologies (BMNR) fell 10% to $26.70 Thursday after an SEC filing showed President Erik Nelson was fired without cause and will receive $605,000 in severance. The drop followed sharp declines in ether and bitcoin prices. BMNR traded nearly 58 million shares, swinging between $29.15 and $26.03. Investors are watching dilution risk after shareholders approved raising authorized stock to 50 billion shares.
BitMine Immersion (BMNR) stock ends higher after $14.5B crypto holdings update as market looks to next session

BitMine Immersion (BMNR) stock ends higher after $14.5B crypto holdings update as market looks to next session

BitMine Immersion shares closed up 3.9% at $29.35 after reporting $14.5 billion in crypto and cash assets, led by 4.2 million ether. Shareholders approved a charter amendment raising authorized shares from 500 million to 50 billion. The company said it recently acquired 35,268 ETH and has staked 1.8 million ether. BitMine’s $200 million investment in Beast Industries is set to close this week.
BMNR stock price slides as BitMine Immersion lifts share cap to 50 billion and updates $14.5 billion crypto stash

BMNR stock price slides as BitMine Immersion lifts share cap to 50 billion and updates $14.5 billion crypto stash

BitMine Immersion Technologies shares fell 2.5% to $27.54 after shareholders approved raising authorized common stock from 500 million to 50 billion. The company reported $14.5 billion in crypto assets and cash, with 4.2 million ether and 193 bitcoin held. Ether dropped 3.1% to $2,904, while bitcoin slid 2.1% to $87,884. Traders anticipate possible new stock offerings and updates on the MAVAN staking plan.
BMNR stock slips as BitMine lifts Ethereum holdings to 4.203 million and wins 50 billion-share authorization vote

BMNR stock slips as BitMine lifts Ethereum holdings to 4.203 million and wins 50 billion-share authorization vote

BitMine Immersion Technologies shares fell 0.7% to $28.05 Wednesday after shareholders approved raising authorized shares from 500 million to 50 billion. The company reported $14.5 billion in crypto and cash holdings, including 4.2 million ETH. Ether dropped nearly 2% during the session. BitMine disclosed a $200 million stake in Beast Industries, not included in its “moonshots” portfolio.
1 2 3

Stock Market Today

  • Rocket Lab Stock Price Forecast: AI Analyst Cautions Despite 60% Surge
    June 9, 2026, 10:12 AM EDT. Shares of Rocket Lab USA ($RKLB) have jumped more than 60% year-to-date due to increased demand for small-satellite launches. Despite the rally, AI-driven analysis from TipRanks highlights caution, urging investors to consider potential market volatility and competitive pressures. Rocket Lab's growth taps into expanding satellite deployment, but risks remain in a crowded aerospace sector. Investors should balance optimism with these cautionary signals from advanced analytics.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Go toTop